Clinical Diagnostics

Clinical diagnostics automation Market Analyzed in a New Research Study – Cole of Duty | 7/19/2020

Clinical diagnostics automation Market Analyzed in a New Research Study – Cole of Duty “ Market Scenario of the Clinical diagnostics automation Market: The most recent Clinical diagnostics automation Market Research study includes some significant activities of the current market size for the worldwide Clinical diagnostics automation market. It presents a point by point analysis dependent on the exhaustive research of the market elements like market size, development situation, potential opportunities, and …

In Vitro Diagnostics (IVD) Products and Test Market (Impact of COVID-19) Top Growing Companies: Abbott Laboratories(US),Becton Dickinson Company(US),bioMerieux SA(France),F. Hoffmann-La Roche Ltd.(Switzerland),Siemens Healthcare(Germany) | 7/18/2020

… Players: Abbott Laboratories(US),Becton Dickinson Company(US),bioMerieux SA(France),F. Hoffmann-La Roche Ltd.(Switzerland),Siemens Healthcare(Germany),Alere Inc(US),Beckman Coulter, Inc.(US),Bio-Rad Laboratories(US),Hologic(US),Ortho Clinical Diagnostics (US),Roche Diagnostics(US). The final report will add the analysis of the Impact of Covid-19 in this report In Vitro Diagnostics (IVD) Products and Test industry. Get a Free Sample Copy @ https …

Follow Clinical Diagnostics:    

2015-2025 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Research by Type, End-Use and Region | 7/17/2020

… etc. Chapter 10: Market Competition by Companies and Market Concentration Ratio Chapter 11: Market Impact by Coronavirus. Chapter 12: Industry Summary . Market Segment as follows: Key Companies R&D Systems Thermo Fisher Scientific Ortho Clinical Diagnostics BD Biosciences ZEUS Scientific Bio-Rad Laboratories ALPCO Enzo Life Sciences BioMérieux EMD Millipore BioLegend LOEWE Biochemica Mercodia Cusabio Shanghai Kehua Bio-engineering Key Types Sandwich ELISA Indirect ELISA Competitive ELISA Others Key End …

IMV ServiceTrak™ Awards for Clinical Laboratory Instruments Announced Today | PR Newswire | 7/17/2020

… Group, the leading market research and business intelligence provider to the laboratory diagnostic industry, announced the category winners of the 2020 IMV ServiceTrak™ awards in clinical analyzers. Chemistry: Best Service: Beckman Coulter and Ortho Clinical Diagnostics Best Customer Satisfaction: Ortho Clinical Diagnostics Best System Performance: Ortho Clinical Diagnostics (PRNewsfoto/IMV Medical Information Division) Immunoassay: Best Service: Beckman Coulter and Ortho Clinical Diagnostics Best Customer Satisfaction: Ortho Clinical Diagnostics Best System …

IMV ServiceTrak(TM) Awards for Clinical Laboratory Instruments Announced Today | 7/17/2020

… Group, the leading market research and business intelligence provider to the laboratory diagnostic industry, announced the category winners of the 2020 IMV ServiceTrak™ awards in clinical analyzers. Chemistry: Best Service: Beckman Coulter and Ortho Clinical Diagnostics Best Customer Satisfaction: Ortho Clinical Diagnostics Best System Performance: Ortho Clinical Diagnostics Immunoassay: Best Service: Beckman Coulter and Ortho Clinical Diagnostics Best Customer Satisfaction: Ortho Clinical Diagnostics Best System Performance: Beckman Coulter and Ortho Clinical Diagnostics Integrated Systems …

Google Alert - nova | 7/16/2020

nova As-it-happens update ⋅ July 16, 2020 NEWS Global Creatinine Analyzer Market Report 2020 Post COVID 19 Pandemic Analysis Edition Top … 3rd Watch News Roche, Siemens, Abbott, Danaher Corporation, Nova Biomedical, PTS Diagnostics, Ortho Clinical Diagnostics , Biotechnologies Inc. Each of the … Flag as irrelevant Blood Gas and Electrolyte Analyzers Market Grow at Exceptional Rate During 2020 to 2026 … 3rd Watch News … Abbott, ERBA Mannheim, Instrumentation Laboratory Company, Medica Corporation …

bioMérieux: Launch of BIOFIRE® MYCOPLASMA Test for Mycoplasma Detection in Biopharmaceutical Products | Business Wire | 7/16/2020

… method that provides results in just a few hours but must be performed in a specialized lab, requiring high-level expertise. “ Based on the BIOFIRE ® technology used for several years in the field of clinical diagnostics , BIOFIRE ® MYCOPLASMA allows our pharma sector customers to carefully monitor the risk of contamination at each step in their manufacturing processes. The simplicity and reliability of this pioneering microbiological control solution for biopharmaceutical products …

RareCyte® announces the Orion™ spatial biology platform with breakthrough technology for same-day highly multiplexed tissue analysis | PR Newswire | 7/16/2020

… team at [email protected] for more information, or visit https://www.rarecyte.com/orion . About RareCyte, Inc. RareCyte offers Precision Biology solutions focused on multiplexed analysis of cells and tissue with applications in both research and clinical diagnostics . The company has deep experience in developing advanced precision life science systems used in cutting-edge labs worldwide. Our customers perform innovative research, bring new therapeutics to market, and perform a wide range of …

Industry Insights on Market Expansion into the US HbA1c Testing Market | Infiniti’s Free downloadable resource provides unparalleled insights | Business Wire | 7/16/2020

… View the full release here: https://www.businesswire.com/news/home/20200716005647/en/ Industry Insights on Market Expansion into the US HbA1c Testing Market (Graphic: Business Wire) In a span of six-weeks the client, a clinical diagnostics market player based out of APAC successfully actioned their market expansion plan in point-of-care testing for the HbA1c market in the United States and recorded substantial revenue growth using a highly targeted …

Global Multiplex Assays (Molecular Multiplexing) Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2024) | PR Newswire | 7/16/2020

… Market Forecast by Value 3.4 Global Multiplex Assays Market by Application 3.4.1 Global Multiplex Assays Research & Development Market by Value 3.4.2 Global Multiplex Assays Research & Development Market Forecast by Value 3.4.3 Global Multiplex Assays Clinical Diagnostics Market by Value 3.4.4 Global Multiplex Assays Clinical Diagnostics Market Forecast by Value 3.4.5 Global Multiplex Assays Companion Diagnostics Market by Value 3.4.6 Global Multiplex Assays Companion Diagnostics Market Forecast by Value 3.5 Global …

[ASAP] Capillary Zone Electrophoresis-Top-Down Tandem Mass Spectrometry for In-Depth Characterization of Hemoglobin Proteoforms in Clinical and Veterinary Samples | 7/15/2020

Hemoglobin (Hb) constitutes an important protein in clinical diagnostics —both in humans and animals. Among the high number of sequence variants, some can cause severe diseases. Moreover, chemical modifications such as glycation and carbamylation serve as important biomarkers for conditions such as diabetes and kidney diseases. In clinical routine analysis of glycated Hb, sequence variants or other Hb proteoforms can cause interference, resulting in wrong quantification results. We present a …

Inmedix welcomes Bernie Tobin, former President of Crescendo Bioscience (Myriad Genetics) to its Board of Directors | 7/15/2020

Seasoned biotech leadership expected to bolster the launch of bloodless, cloud-based, clinical diagnostics at Inmedix, Inc. NORMANDY PARK, WA, USA, July 15, 2020 / EINPresswire.com / – In its continuing effort to define immuno-autonomics affecting patients with autoimmune disease using its bloodless, cloud-based, clinical diagnostics platform, Inmedix today announced that it has appointed Bernie Tobin to its Board of Directors. Mr. Tobin was most recently with Crescendo Bioscience, a wholly …

Lab Automation Industry Growth (Drug Discovery, Clinical Diagnostics, Genomics) Worth $5.20 Billion | 7/15/2020

Lab Automation Industry Growth (Drug Discovery, Clinical Diagnostics, Genomics) Worth $5.20 Billion Discover The Latest Trends ,Growth Opportunities, Largest Revenue Generating Region and Latent Adjacency 15, 2020 ) According to a new market research report “ Lab Automation Market by Equipment and Software (Robotic Arms, Microplate Readers, LIMS), Applications (Drug Discovery, Clinical Diagnostics, Genomics), End Users (Biotechnology and Pharmaceuticals, Diagnostic Labs) - Global Forecast to 2022”, published by MarketsandMarkets™, the market is expected …

Australia Microfluidics Market to Undergo Significant Growth Through 2025 | 7/14/2020

… to TechSci Research report, “Australia Microfluidics Market By Component Type (Microfluidic Chips, Microfluidic Sensors, Microfluidic Pumps, Microneedles, Others), By Material (Polymer, Glass, Silicon, PDMS, Other), By Application (In Vitro diagnostics (Point-of-Care Testing, Clinical Diagnostics , Environmental Testing, Industrial Testing, Agro Food Testing), Pharmaceutical Research (Lab Analytics, Microdispensing, Microreaction), Drug Delivery (Inhaler Nozzles, Microneedles, Micropumps), By Region, Forecast & Opportunities, 2025”, the market is expected to grow at a significant CAGR …

Australia Microfluidics Market to Undergo Significant Growth Through 2025 – TechSci Research | 7/14/2020

… to TechSci Research report, “ Australia Microfluidics Market By Component Type (Microfluidic Chips, Microfluidic Sensors, Microfluidic Pumps, Microneedles, Others), By Material (Polymer, Glass, Silicon, PDMS, Other), By Application (In Vitro diagnostics (Point-of-Care Testing, Clinical Diagnostics , Environmental Testing, Industrial Testing, Agro Food Testing), Pharmaceutical Research (Lab Analytics, Microdispensing, Microreaction), Drug Delivery (Inhaler Nozzles, Microneedles, Micropumps), By Region, Forecast & Opportunities, 2025” , the market is expected to grow at a significant CAGR …

Global Automated and Rapid Microbiological Tests Industry | 7/14/2020

Global Automated and Rapid Microbiological Tests Industry By Reportlinker Read the full report: https://www.reportlinker.com/p04707098/?utm_source=PRN Amid the COVID-19 crisis, the global market for Automated and Rapid Microbiological Tests estimated at US$5.2 Billion in the year 2020, is projected to reach a revised size of US$7.8 Billion by 2027, growing at a CAGR of 5.8% over the analysis period 2020-2027.GC/CRT (Clinical), one …

FTC, medical company settle false Privacy Shield claims | 7/14/2020

The U.S. Federal Trade Commission announced a finalized settlement with Ortho-Clinical Diagnostics over falsified EU-U.S. Privacy Shield participation. The medical devices and services provider claimed it was Privacy Shield certified despite a lapse in certification in 2018. The FTC voted 4–0–1 on the settlement with Commissioner Rebecca Kelly Slaughter not participating. Ortho-Clinical Diagnostics is prohibited from further misrepresentations and required to protect previously collected information …

Novacyt SA (“Novacyt”, the “Company” or the “Group”): half-yearly commercial update | 7/13/2020

Read more PARIS AND CAMBERLEY, England – ( BUSINESS WIRE ) – Regulatory news: Novacyt (EURONEXT GROWTH: ALNOV; OBJECTIVE: NCYT), an international specialist in clinical diagnostics , announces an uncertified commercial update for the six months ended June 30, 2020. Commercial update Non-certified revenue for the first half of 2020 increased 900% to € 72.4 million (£ 63.3 million), compared to revenue of € 7.2 million (£ 6.3 million) in the first half of 2019, with 91% of …

Novacyt S.A. (“Novacyt”, the “Company” or the “Group”): Half-Year Trading Update | Business Wire | 7/13/2020

PARIS & CAMBERLEY, England- Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics , announces an unaudited trading update for the six months ended 30 June 2020. Trading update Unaudited revenue for the first half of 2020 increased over 900% to €72.4 million (£63.3 million), compared to revenue of €7.2 million (£6.3 million) for the first half of 2019, with 91% of revenue accounted for in the …

Thermo Fisher Scientific and First Genetics JCS Partner to Develop Next-Generation Sequencing-Based Diagnostics in Russia | PR Newswire | 7/13/2020

… of NGS into reproductive medicine in Russia , and in the future, we intend to offer clinically certified solutions for other clinical applications, such as oncology testing. This is our contribution to the development of clinical diagnostics in Russia .” Thermo Fisher has entered into a number of agreements with assay developers like First Genetics to expand the use of NGS-based molecular diagnostics in the clinic and to advance precision medicine …

CFO Moves – week ending July 10, 2020 | 7/13/2020

… before transitioning to the General Manager of the miraDry® business unit. Prior to Sientra, Williams was Chief Financial Officer of ZELTIQ Aesthetics, Inc. Williams has also served as Vice President at NuVasive, Inc. Ortho Clinical Diagnostics [RARITAN, NJ] announced Joseph M. Busky has joined the Company as Chief Financial Officer. Busky previously served as Chief Financial Officer for Vyaire Medical, Inc. Prior to Vyaire, Busky was Chief Financial Officer of …

FTC Finalizes Privacy Shield Settlement with Ortho-Clinical | 7/13/2020

The Federal Trade Commission has finalized a settlement with a medical diagnostic devices and services company over allegations the firm misled consumers about its participation in the EU-U.S. Privacy Shield framework. The FTC alleged that New Jersey-based Ortho-Clinical Diagnostics, Inc. claimed that it participated in the Privacy Shield framework and complied with the program’s requirements, even though the company had allowed its certification to lapse in 2018 …

Liquid Chromatography Instruments Market Research: Global Status and Forecast by Geography, Type and Application (2016-2026) | 7/13/2020

… Phenomenex Shimadzu Thermo Fisher Scientific Waters Corporation Key Product Type High Performance Liquid Chromatography (HPLC) Ultra High Pressure Liquid Chromatography (UHPLC) Low Pressure Liquid Chromatography (LPLC) Fast Protein Liquid Chromatography (FPLC) Market by Application Clinical Diagnostics Environmental Testing Food and Beverage Analysis Forensic Tests Life Sciences Main Aspects covered in the Report Overview of the Liquid Chromatography Instruments market including production, consumption, status & forecast and market growth 2016-2020 historical data …

[ASAP] Quantum Nuts: Two Shells Are Better than One to Achieve Highly Efficient Electrochemiluminescence | 7/10/2020

… and complexity from both electrochemistry and photophysics. ECL is successfully commercialized for a large number of immunoassays, such as cardiac and infectious diseases, thyroid, tumor markers, etc. Almost two billion ECL-based assays for clinical diagnostics are run worldwide each year. (1) Since it is based on an optical readout, ECL has also evolved into a powerful imaging method. (3) Most of the applications still rely on the model [Ru …

Clinical Diagnostics Automation Market Share, Growth Forecast- Global Industry Outlook – Cole of Duty | 7/9/2020

To Purchase This Report: https://www.upmarketresearch.com/buy/clinical-diagnostics-automation-market The Clinical Diagnostics Automation Market Report Addresses: Estimated size of the market The segment that accounted for a large market share in the past The segment that is anticipated to account for a dominant market share by 2026? Governing bodies Key region of the market Lucrative opportunities in the market The Report Provides: An overview of the market Comprehensive …

COVID-19

Analysis on Impact of COVID-19- Global Chromatography Market 2020-2024 | Evolving Opportunities with Agilent Technologies Inc. and Bio-Rad Laboratories Inc. | Technavio | Business Wire | 7/9/2020

… per Technavio. This marks a significant market growth compared to the 2019 growth estimates due to the impact of the COVID-19 pandemic in the first half of 2020. Moreover, steady growth is expected to … Inc. operates its business through two segments: life science and clinical diagnostics. The company’s key offerings include the NGC 10 Medium-Pressure Chromatography System, which is used for purifying biomolecules for analytical and preparative-scale …

Food and Drug Administration

Luminex Submits Emergency Use Authorization Request to U.S. FDA for COVID-19 Antibody Test | PR Newswire | 6/29/2020

… Texas Luminex Corporation (NASDAQ: LMNX ) today announced that the company has submitted an Emergency Use Authorization request to the U.S. Food and Drug Administration (FDA) for its xMAP ® SARS-CoV-2 Multi-Antigen IgG assay … a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. We accelerate reliable answers while simplifying complexity and deliver …

Biotech

Global Respiratory Syncytial Virus Diagnostics Market 2020-2024 | Evolving Opportunities with Abbott Laboratories and Becton, Dickinson and Co. | Technavio | Business Wire | 6/26/2020

… offering RSV diagnosis test kits for testing COVID-19. For instance, the US FDA recently approved the use of Mesa Biotech’s Accula device for COVID-19 which gives results in about 30 minutes. The use … operates its business through segments such as Life Science and Clinical Diagnostics. The company offers Mouse anti Respiratory Syncytial Virus Fusion Protein that recognizes virus antigen and it is validated for ELISA, Immunofluorescence, and Immunohistochemistry …

CDC

Biocare Medical MACH4 Universal Polymer Utilized by CDC for Immunohistochemical Detection of SARS-CoV-2 in COVID-19 Caused Respiratory Infections | PR Newswire | 6/24/2020

… an urgent need for new research into diagnostic testing and treatments. As a part of the public health response, the CDC Infectious Diseases Pathology Branch has been examining the histopathology and cellular localization of the … have been designed to meet every need from high throughput clinical diagnostics to flexible research requirements. Biocare Medical’s corporate headquarters and operations are based in the San Francisco Bay Area with a global distribution network …

Diagnostic Tests

Global Market Outlook for the Coronavirus Diagnostics Market to 2027 | PR Newswire | 6/19/2020

… the market growth.Based on type, the serology tests segment is going to experience lucrative growth during the forecast period as diagnostic tests are done using blood samples. Furthermore, these tests are helpful in determining patients … Company, bioMerieux, Bio-Rad Laboratories, GSK Biologicals, Hologic, Lonza, Ortho-Clinical Diagnostics, PerkinElmer, Qiagen and Roche Diagnostics. What the report offers: Market share assessments for the regional and country-level segments Strategic recommendations for the …

Patient Management

BARDA and Ortho Collaborate to Advance Development of High Specificity SARS-CoV-2 Antibody Tests | PR Newswire | 6/17/2020

RARITAN, N.J. Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced it is collaborating with Biomedical Advanced Research and Development Authority ( BARDA ), a component of the Office of the Assistant Secretary for … recovery. The tests offer greater choice in tracking, surveillance and patient management. As noted on the U.S. Food and Drug Administration’s website, test results also can help aid in determining who may be eligible to …

NIH

Pop-Up Testing Lab Shows Volunteer Spirit Against Deadly Pandemic | National Institutes of Health (NIH) | 6/10/2020

… NIH-supported structural biochemist with no experience in virology or clinical diagnostics, decided that she and her IGI colleagues could establish a pop-up testing lab at their facility. Their job: boost the SARS-CoV-2 testing capacity in her community. It was a great idea, but a difficult one to execute. The first daunting step was acquiring Clinical Laboratory Improvement Amendments (CLIA) certification. This U. S. certification ensures that …

Genomics

Pop-Up Testing Lab Shows Volunteer Spirit Against Deadly Pandemic | National Institutes of Health (NIH) | 6/10/2020

Caption: Postdoc Jenny Hamilton volunteered to work on coronavirus testing at the Innovative Genomics Institute. Behind her is one of the lab’s liquid-handling systems, which robotically extracts RNA from patient samples before another machine … NIH-supported structural biochemist with no experience in virology or clinical diagnostics, decided that she and her IGI colleagues could establish a pop-up testing lab at their facility. Their job: boost the SARS-CoV …

Medicare

Webinar: Utilizing Regional Testing Capacity to fight COVID-19 | Modern Healthcare | 5/6/2020

… a highly distinguished record in public service and academic research, Dr. McClellan is a former administrator of the Centers for Medicare & Medicaid Services and former commissioner of the U.S. Food and Drug Administration (FDA), where … Gary was previously the CEO of LabCorp Diagnostics, a $7B clinical diagnostics organization. Before becoming CEO, Huff served as the senior vice president of health systems and strategic alliances for LabCorp Diagnostics. Before joining LabCorp …

Medicaid

Webinar: Utilizing Regional Testing Capacity to fight COVID-19 | Modern Healthcare | 5/6/2020

… highly distinguished record in public service and academic research, Dr. McClellan is a former administrator of the Centers for Medicare & Medicaid Services and former commissioner of the U.S. Food and Drug Administration (FDA), where he … Gary was previously the CEO of LabCorp Diagnostics, a $7B clinical diagnostics organization. Before becoming CEO, Huff served as the senior vice president of health systems and strategic alliances for LabCorp Diagnostics. Before joining LabCorp …

National Institutes of Health

FDA, CDC, NIH to begin validating COVID-19 antibody tests as more enter the market | FierceBiotech | 4/20/2020

… with the Centers for Disease Control and Prevention as well as the infectious disease and cancer research arms of the National Institutes of Health (NIH) to help generate validation data and make sure blood tests … products include an automated, high-throughput test manufactured by Ortho Clinical Diagnostics for its Vitros system; a rapid, point-of-care, fingerstick blood test by ChemBio Diagnostics ; and a highly sensitive enzyme-linked immunosorbent assay …

Companion Diagnostics

Global Cardiac Biomarkers Industry | PR Newswire | 4/14/2020

… Corporation Beckman Coulter Inc. BG Medicine bioMérieux SA Boditech Med Inc. Labsystems Diagnostics OY LifeSign LLC LSI Medience Corp. Ortho-Clinical Diagnostics Inc. Randox Laboratories Response Biomedical Corp. Roche Diagnostics Corp. Siemens Healthineers Merck KGaA … Commercialization of Novel Biomarkers to Drive Market Growth Personalized Medicine, Companion Diagnostics Open Up Opportunities for Cardiac Biomarker Developers Cardiac Biomarkers - A Powerful Tool for Patient Triaging Cardiac Biomarkers Market Transitions from Mono-Marker to …

Health Research

Global C-Reactive Protein Testing Market Expected to Grow with a CAGR of 1.3% During the Forecast Period, 2020-2027 - ResearchAndMarkets.com | Business & Finance | heraldchronicle.com | Business Wire | 3/13/2020

… for research entities that are engaged in performing research activities in this area, boost market progression. The National Institute for Health Research, the Wellcome Trust, and the Department for International Development are among the few … reinforce their market presence For instance, in May 2018, Ortho Clinical Diagnostics signed an agreement with Sentinel Diagnostics to develop CRP Ultra (MP) Assay for future CRP testing in hospitals and laboratories. Key Topics Covered …

Oncology Diagnostics

Viracor Eurofins Expands Its Clinical Diagnostic Footprint to Oncology | Yahoo News | 12/11/2019

Viracor Eurofins (Viracor), proudly announces the addition of span class=”xn-person” Karina Eterovic /span , PhD, as the Director of Research & Development for Oncology Diagnostics for Eurofins U.S. Clinical Diagnostics group. Dr. Eterovic will lead the development and growth of oncology clinical diagnostic solutions to benefit our healthcare clients and their patients.” data-reactid=”12” LEE’S SUMMIT, Mo. , Dec. 11, 2019 /PRNewswire/ – Viracor Eurofins (Viracor), proudly announces the addition of …

Precision Medicine

Analysis on the World Market for Biomarkers 2016-2019 & 2025: Key Trends, Discovery Techniques & Applications | Globe Newswire | 12/4/2019

… NEO Systems by Bruker NanoString Collaborated with National Cancer Institute to Improve Cancer Immunotherapy Biomarker Discovery Thermo Fisher Scientific Opens Precision Medicine Science Center in The United States Myriad Genetics to Acquire Counsyl Thermo Fisher … Illumina and Extends the Application of MiSeqTM Dx System Ortho Clinical Diagnostics to Use EKF Diagnostics’ Diabetic Ketoacidosis Assay Thermo Fisher Scientific and Blueprint Medicines Ink Deal for Oncology Companion Diagnostic Development Expansion of laboratory …

Cancer Therapy

Global Polymerase Chain Reaction (PCR) Market 2019-2025: Increasing Demand for PCR in Genetic and Molecular Testing | PR Newswire | 12/4/2019

… technological advancements and growing demand for rapid diagnostic tests. However, factors like the high cost of commercial PCR assays in clinical diagnostics, lack of awareness and requirement of skilled labor, development of alternate technologies and … and others. Non-infectious diseases include prenatal diagnosis, tissue typing, cancer therapy, genetic typing for hereditary disease, blood screening, and others. Industrial applications are divided into Agricultural, Environment, Applied testing, Animal husbandry, biomedical research, and …

Virginia Commonwealth University

RightEye’s Parkinson’s test just took a big step forward. Now it’s eyeing a $15M funding round. | 12/4/2019

… major unmet medical need. The decision thrusts RightEye, whose medical device tracks eye movement to uncover vision behavior, into the clinical diagnostics space for the first time. Now, the firm is setting out to raise … its Parkinson’s disease test. That test — developed by researchers at Virginia Commonwealth University and the Department of Veterans Affairs, funded by the Michael J. Fox Foundation and acquired by RightEye in 2016 — measures a person’s …

Regenerative Medicine

Global Hematology Partnering Deal Trends, Players and Financials 2014-2019 | Globe Newswire | 12/4/2019

… Blood Center Boryung Pharmaceutical Bristol-Myers Squibb Bristol-Myers Squibb Foundation C-Bridge Capital Cadila Pharmaceuticals Calbiotech California Institute for Regenerative Medicine Calithera Biosciences Capnia Cardiome Pharma Casebia Therapeutics Case Western Reserve University Catalyst Biosciences … Novartis NovImmune Novo Nordisk Nxstage Medical Octapharma OMRF OrSense Ortho-Clinical Diagnostics Otsuka Oxford BioMedica Palex Medical Pan American Cancer Treatment Centers PathoQuest Pathway Diagnostics PBM Capital Group Peking University Pfenex Pfizer Pfizer Japan Pharmacosmos …

Centers for Medicare and Medicaid Services

Medicare Sets National Price for KidneyIntelX™ | PR Newswire | 12/3/2019

Medicare Sets National Price for KidneyIntelX™ National pricing of $950 effective as of January 1st, 2020 News provided by Dec 03, 2019, 12:03 ET Share this article NEW YORK , Dec. 3, 2019 /PRNewswire/ – Renalytix AI plc (LSE: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announced today that the Centers for Medicare and Medicaid Services (“CMS”) has released the Final 2020 Clinical Laboratory Fee Schedule (“CLFS …

Medical Electronics

Sterility Testing Market is Booming | Ortho Clinical Diagnostics, F. Hoffmann-La Roche Ltd, VirtualExpo | 11/29/2019

… Clinical Diagnostics, F. Hoffmann-La Roche Ltd, VirtualExpo, bioMérieux SA, Danaher., Siemens, DuPont., DSM, Novozymes, Bio-Techne., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Quidel Corporation., PerkinElmer Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BD and Merck KGaA, among others. The Global Sterility Testing Market accounted to USD 989.3 million by 2021 growing at a CAGR of 13.3% during the forecast period of 2017 to 2024. For Better Understanding …

National Cancer Institute

Global Immunoassay Market Outlook and Forecast to 2025 - Leading Vendors are Roche Diagnostics, bioMerieux, Abbott Laboratories, Becton Dickinson & Company, and Siemens Healthineers | PR Newswire | 11/28/2019

… broad array of applications in disease diagnosis with high specificity and sensitivity when compared to other tests. According to the National Cancer Institute, in the US, an estimated 1,735,530 new cancer cases were diagnosed and … due to improved healthcare infrastructure, high usage of immunoassays in clinical diagnostics, and favorable reimbursement facilities. Competitive Analysis The market players are continuously focusing on R&D to deliver innovative products in the market. The …

Research Genomics

Luminex Corporation to Present at the Piper Jaffray 31st Annual Healthcare Conference on December 4, 2019 | PR Newswire | 11/25/2019

… About Luminex Corporation At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. We accelerate reliable answers while simplifying complexity and deliver certainty with a seamless experience. To learn more about Luminex, please visit …

Pain Management

Ortho Clinical Diagnostics Expands Drug Assay Menus to Include Fentanyl and Tricyclic Antidepressant | 11/22/2019

Ortho Clinical Diagnostics Expands Drug Assay Menus to Include Fentanyl and Tricyclic Antidepressant Published on November 22, 2019 Ortho Clinical Diagnostics, Raritan, NJ, in collaboration with Thermo Fisher Scientific, Waltham, Mass, has expanded the menus … fentanyl. Fentanyl is a synthetic opiate analgesic prescribed for chronic pain management and is a potentially deadly drug when abused because it is 50 to 100 times stronger than morphine. The US Drug Enforcement Administration …

Biosensors

Gas-Phase Synthesis for Label-Free Biosensors: Zinc-Oxide Nanowires Functionalized with Gold Nanoparticles | Nature | 11/22/2019

… sensitive and label-free detection of a wide range of biomolecules. Download PDF Introduction DNA detection has many applications in clinical diagnostics and biomedical research, prompting development in a large variety of methods to detect … other interfering substances are present. Normally, the selectivity of nanowire biosensors is defined by immobilizing receptor molecules on the nanowire surface to uniquely bind to the targeted analyte, such as a complementary DNA strand. Many …

Syndromic Testing

QIAGEN Expands Existing Deal With LabCorp for Better Treatment | Zacks | 11/21/2019

… provides a flexible technology platform which makes it possible to use highly targeted (rather than large-scale) test panels for clinical diagnostics, and in studies of new therapies and diagnostics. A Peek Into HGMD More … inherited diseases in June. In May, QIAGEN launched QIAstat-Dx syndromic testing system in the United States, after receiving FDA clearance. It also launched multiplex QIAstat-Dx Respiratory Panel in the same period. Industry Prospects …

Siemens

IMV ServiceTrak™ Awards for Clinical Laboratory Instruments Announced Today | PR Newswire | 7/17/2020

… announced the category winners of the 2020 IMV ServiceTrak™ awards in clinical analyzers. Chemistry: Best Service: Beckman Coulter and Ortho Clinical Diagnostics Best Customer Satisfaction: Ortho Clinical Diagnostics Best System Performance: Ortho Clinical Diagnostics (PRNewsfoto … Service: Beckman Coulter Best Customer Satisfaction: Beckman Coulter , Roche, and Siemens Healthineers Best System Performance: Beckman Coulter and Siemens Healthineers Blood Gas: Best Service: OPTI Medical Systems and Radiometer America Best Customer Satisfaction: Instrumentation Laboratory …

Thermo Fisher

Thermo Fisher Scientific and First Genetics JCS Partner to Develop Next-Generation Sequencing-Based Diagnostics in Russia | PR Newswire | 7/13/2020

CARLSBAD, Calif. Thermo Fisher Scientific and First Genetics JCS, a manufacturer of diagnostic equipment and IVD kits intended to advance molecular genetic technologies into clinical practice, today announced a strategic partnership focused on commercializing next … oncology testing. This is our contribution to the development of clinical diagnostics in Russia .” Thermo Fisher has entered into a number of agreements with assay developers like First Genetics to expand the use of NGS …

Thermo Fisher Scientific

Thermo Fisher Scientific and First Genetics JCS Partner to Develop Next-Generation Sequencing-Based Diagnostics in Russia | PR Newswire | 7/13/2020

CARLSBAD, Calif. Thermo Fisher Scientific and First Genetics JCS, a manufacturer of diagnostic equipment and IVD kits intended to advance molecular genetic technologies into clinical practice, today announced a strategic partnership focused on commercializing next … oncology testing. This is our contribution to the development of clinical diagnostics in Russia .” Thermo Fisher has entered into a number of agreements with assay developers like First Genetics to expand the use of NGS …

Quest Diagnostics

Bio-Rad (BIO) Banks on Coronavirus PCR Tests Amid Cost Woes - July 9, 2020 - Zacks.com | 7/9/2020

… is a concern. The stock currently carries a Zacks Rank 3 (Hold). This California-based manufacturer and global supplier of clinical diagnostics and life-science research products has been outperforming its industry for the past … Some better-ranked stocks from the broader medical space are Quest Diagnostics Incorporated ( DGX - Free Report ) , Abbott Laboratories ( ABT - Free Report ) and QIAGEN N.V. ( QGEN - Free Report ) . Quest Diagnostics’ long-term earnings growth rate is …

Bio-Rad Laboratories

Analysis on Impact of COVID-19- Global Chromatography Market 2020-2024 | Evolving Opportunities with Agilent Technologies Inc. and Bio-Rad Laboratories Inc. | Technavio | Business Wire | 7/9/2020

Bio-Rad Laboratories Inc. Bio-Rad Laboratories Inc. operates its business through two segments: life science and clinical diagnostics. The company’s key offerings include the NGC 10 Medium-Pressure Chromatography System, which is used for purifying biomolecules for analytical and preparative-scale applications. Danaher Corp. Danaher Corp. has business operations under various segments, such as life sciences, diagnostics, and environmental and applied solutions. The company offers Zebron ZB-5, which …

Luminex

Luminex Corporation Pre-Release of 2nd Quarter 2020 Revenue | PR Newswire | 7/8/2020

Luminex Corporation Pre-Release of 2nd Quarter 2020 Revenue Second Quarter Earnings Call Scheduled for August 3, 2020 News provided by Jul 08, 2020, 07:00 ET Share this article AUSTIN, Texas , July 8, 2020 /PRNewswire … a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. We accelerate reliable answers while simplifying complexity and deliver …

Qiagen

Global Market Outlook for the Coronavirus Diagnostics Market to 2027 | PR Newswire | 6/19/2020

… Clinical Diagnostics, PerkinElmer, Qiagen and Roche Diagnostics. What the report offers: Market share assessments for the regional and country-level segments Strategic recommendations for the new entrants Covers Market data for the years 2017, 2018, 2019, 2023 and 2027 Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) Strategic recommendations in key business segments based on the market estimations Competitive landscaping mapping the key common trends Company profiling …

GSK

Global Market Outlook for the Coronavirus Diagnostics Market to 2027 | PR Newswire | 6/19/2020

GSK Biologicals, Hologic, Lonza, Ortho-Clinical Diagnostics, PerkinElmer, Qiagen and Roche Diagnostics. What the report offers: Market share assessments for the regional and country-level segments Strategic recommendations for the new entrants Covers Market data for the years 2017, 2018, 2019, 2023 and 2027 Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) Strategic recommendations in key business segments based on the market estimations Competitive landscaping mapping the …

Roche Diagnostics

Global Market Outlook for the Coronavirus Diagnostics Market to 2027 | PR Newswire | 6/19/2020

… Clinical Diagnostics, PerkinElmer, Qiagen and Roche Diagnostics. What the report offers: Market share assessments for the regional and country-level segments Strategic recommendations for the new entrants Covers Market data for the years 2017, 2018, 2019, 2023 and 2027 Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) Strategic recommendations in key business segments based on the market estimations Competitive landscaping mapping the key common trends Company profiling …

Becton, Dickinson and Company

Global Market Outlook for the Coronavirus Diagnostics Market to 2027 | PR Newswire | 6/19/2020

… Becton, Dickinson and Company, bioMerieux, Bio-Rad Laboratories, GSK Biologicals, Hologic, Lonza, Ortho-Clinical Diagnostics, PerkinElmer, Qiagen and Roche Diagnostics. What the report offers: Market share assessments for the regional and country-level segments Strategic recommendations for the new entrants Covers Market data for the years 2017, 2018, 2019, 2023 and 2027 Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) Strategic recommendations in key business segments based …

Abbott Laboratories

World Immuno-Oncology Diagnostics Market Forecasts to 2024 and the Impact of the COVID-19 Outbreak on the Sector | PR Newswire | 6/16/2020

… 4.2 Factors Limiting Growth 4.3 Diagnostic Technology Development 5. Cancer Immunotherapy Recent Developments 6. Profiles of Key Immunotherapy Companies Genomics Abbott Laboratories Abcam Adaptive Biotechnologies Aethlon Medical Agena Bioscience Angle plc Apocell ARUP Laboratories Beckman … Genetics/Myriad RBM Nanostring Natera Neogenomics New Oncology Oncocyte Ortho Clinical Diagnostics Perkin Elmer Personal Genome Diagnostics Pfizer Promega Protagen Diagnostics Qiagen Quanterix Rarecells SAS Roche Diagnostics Siemens Silicon Biosystems SkylineDx SRI International Sysmex Thermo …

Biodesix

World Immuno-Oncology Diagnostics Market Forecasts to 2024 and the Impact of the COVID-19 Outbreak on the Sector | PR Newswire | 6/16/2020

… Abcam Adaptive Biotechnologies Aethlon Medical Agena Bioscience Angle plc Apocell ARUP Laboratories Beckman Coulter Becton Dickinson Bioarray Genetics BioCartis Biocept Biodesix Inc BioFluidica BioGenex bioMrieux Bio-Rad Bio-Techne Bristol- Myers Squibb Cancer Genetics Caris … Genetics/Myriad RBM Nanostring Natera Neogenomics New Oncology Oncocyte Ortho Clinical Diagnostics Perkin Elmer Personal Genome Diagnostics Pfizer Promega Protagen Diagnostics Qiagen Quanterix Rarecells SAS Roche Diagnostics Siemens Silicon Biosystems SkylineDx SRI International Sysmex Thermo …

Biocept

World Immuno-Oncology Diagnostics Market Forecasts to 2024 and the Impact of the COVID-19 Outbreak on the Sector | PR Newswire | 6/16/2020

… Laboratories Abcam Adaptive Biotechnologies Aethlon Medical Agena Bioscience Angle plc Apocell ARUP Laboratories Beckman Coulter Becton Dickinson Bioarray Genetics BioCartis Biocept Biodesix Inc BioFluidica BioGenex bioMrieux Bio-Rad Bio-Techne Bristol- Myers Squibb Cancer Genetics … Genetics/Myriad RBM Nanostring Natera Neogenomics New Oncology Oncocyte Ortho Clinical Diagnostics Perkin Elmer Personal Genome Diagnostics Pfizer Promega Protagen Diagnostics Qiagen Quanterix Rarecells SAS Roche Diagnostics Siemens Silicon Biosystems SkylineDx SRI International Sysmex Thermo …

Siemens Healthineers

Global Immunodiagnostic Analyzers & Reagents Market to 2024 - Shares & Forecasts for Over 100 Tests - ResearchAndMarkets.com | Business & Finance | manchestertimes.com | Business Wire | 6/12/2020

… Clinical Diagnostics, PerkinElmer, Quest Diagnostics, Roche, Siemens Healthineers, Sysmex, Thermo Fisher, Tosoh, Wako. Geographic Coverage …

Grifols

Global Immunodiagnostic Analyzers & Reagents Market to 2024 - Shares & Forecasts for Over 100 Tests - ResearchAndMarkets.com | Business & Finance | manchestertimes.com | Business Wire | 6/12/2020

… Grifols, Instrumentation Laboratory/Werfen, Kyowa Medex, Ortho-Clinical Diagnostics, PerkinElmer, Quest Diagnostics, Roche, Siemens Healthineers, Sysmex, Thermo Fisher, Tosoh, Wako. Geographic Coverage …

Adaptive Biotechnologies

Adaptive Biotechnologies and Microsoft launch groundbreaking ImmuneCODE database to share populationwide immune response to the COVID-19 virus | PR Newswire | 6/11/2020

SEATTLE and REDMOND, Wash. , June 11, 2020 /PRNewswire/ – Adaptive Biotechnologies Corp. (Nasdaq: ADPT ) on Thursday launched ImmuneCODE with Microsoft Corp. (Nasdaq: MSFT ) to begin sharing one of the largest, most detailed views of the immune … precision and speed to develop products in life sciences research, clinical diagnostics, and drug discovery. We have two commercial products, and a robust clinical pipeline to diagnose, monitor and enable the treatment of diseases such …

Microsoft Health

Adaptive Biotechnologies and Microsoft launch groundbreaking ImmuneCODE database to share populationwide immune response to the COVID-19 virus | PR Newswire | 6/11/2020

SEATTLE and REDMOND, Wash. , June 11, 2020 /PRNewswire/ – Adaptive Biotechnologies Corp. (Nasdaq: ADPT ) on Thursday launched ImmuneCODE with Microsoft Corp. (Nasdaq: MSFT ) to begin sharing one of the largest, most detailed views of the immune … precision and speed to develop products in life sciences research, clinical diagnostics, and drug discovery. We have two commercial products, and a robust clinical pipeline to diagnose, monitor and enable the treatment of diseases such …

Regeneron Pharmaceuticals

DNAnexus raises $100M for a cloud-based analytics platform aimed at genomics and other clinical big data | TechCrunch | 6/9/2020

… Foresite Capital, TPG Capital and First Round Capital. DNAnexus is also picking up a new strategic backer in this round: Regeneron Pharmaceuticals — one of several companies currently working on antibody therapies for COVID-19 recovery … the platform is used by eight of the top 10 clinical diagnostics companies and seven of the world’s biggest pharmaceutical companies, which use 10 million core processing hours each month and store 28 petabytes of …

Chembio

Global COVID-19 Diagnostic Testing Industry 2020-2025 - Key Market Insights, Vaccine Developments, Competitive Landscape | PR Newswire | 6/5/2020

Chembio Diagnostics are among the dynamic market players working for the purpose of care commercial center. The WHO has encouraged healthcare organizations to focus on COVID-19 indicative testing in light of this emergency. The companies are also adopting profitable strategic moves to gain a competitive edge in the market. For example, in May 2020 , Quest Diagnostics announced its collaboration with Ortho Clinical Diagnostics aimed at the expansion of COVID …

Leica Biosystems

Competing in the 2020 Global Sexually-Transmitted Disease (STD) Testing Market - ResearchAndMarkets.com | Business Wire | 5/27/2020

Leica Biosystems Lonza Ortho-Clinical Diagnostics PerkinElmer Qiagen Roche Scienion Sequenom SeraCare Siemens Healthineers Takara Bio Thermo Fisher Wako //www.researchandmarkets.com/r/a93b48 About ResearchAndMarkets.com ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends …

LabCorp

European Nucleic Acid Testing/NAT Market 2020: Sales and Market Shares of Major Suppliers Including Abbott, Arca Biopharma, Biokit and Shimadzu - ResearchAndMarkets.com | Yahoo News | 5/26/2020

LabCorp Leica Biosystems Li-Cor Biosciences Myriad Genetics Ortho-Clinical Diagnostics PerkinElmer Proteome Sciences Qiagen Roche Scienion Sequenom Shimadzu Siemens Healthineers Sierra Molecular Takara Bio Tecan Group Thermo Fisher List of Tables France Molecular Diagnostics Market By Major Supplier France HIV/Hepatitis NAT Market Reagent Sales By Major Supplier Germany Molecular Diagnostics Market by Major Supplier Germany HIV/Hepatitis NAT Market Reagent Sales by Major Supplier Italy Molecular Diagnostics Market …

Bio-Techne

Leica Biosystems and Bio-Techne Announce European Launch of the CE-IVD RNAscope In Situ Hybridization Detection Kit | PR Newswire | 5/26/2020

MINNEAPOLIS , May 26, Bio-Techne (NASDAQ: TECH ), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities and Leica Biosystems, a global leader in workflow solutions and automation, are proud to announce the European launch of the CE-IVD marked RNAscope™ In Situ Hybridization Detection Kit for automation on the BOND-III platform. The combination of Bio-Techne’s RNAscope and Leica’s BOND …

Illumina

European Nucleic Acid Testing/NAT Market 2020: Sales and Market Shares of Major Suppliers Including Abbott, Arca Biopharma, Biokit and Shimadzu - ResearchAndMarkets.com | Yahoo News | 5/26/2020

Illumina LabCorp Leica Biosystems Li-Cor Biosciences Myriad Genetics Ortho-Clinical Diagnostics PerkinElmer Proteome Sciences Qiagen Roche Scienion Sequenom Shimadzu Siemens Healthineers Sierra Molecular Takara Bio Tecan Group Thermo Fisher List of Tables France Molecular Diagnostics Market By Major Supplier France HIV/Hepatitis NAT Market Reagent Sales By Major Supplier Germany Molecular Diagnostics Market by Major Supplier Germany HIV/Hepatitis NAT Market Reagent Sales by Major Supplier Italy Molecular Diagnostics …

Genomic Health

Medical Device Innovation Consortium Seeks Public Comment on In Vitro Diagnostics Real-World Evidence Framework | Business Wire | 5/20/2020

clinical diagnostics program director for MDIC. “In combatting the COVID-19 pandemic, epidemiological surveillance using Electronic Health Records, Laboratory Information Systems, industry databases, and other public and private sources can identify hot spots and effective treatments.” Industry partners involved in creating the IVD RWE Framework include Abbott Diagnostics, Genomic Health, Hologic, IBM Watson, ICON plc, Johnson & Johnson, Roche Diagnostics, Sysmex America, and Thermo Fisher Scientific. Individual subject matter experts in …

Johnson & Johnson

Medical Device Innovation Consortium Seeks Public Comment on In Vitro Diagnostics Real-World Evidence Framework | Business Wire | 5/20/2020

clinical diagnostics program director for MDIC. “In combatting the COVID-19 pandemic, epidemiological surveillance using Electronic Health Records, Laboratory Information Systems, industry databases, and other public and private sources can identify hot spots and effective treatments.” Industry partners involved in creating the IVD RWE Framework include Abbott Diagnostics, Genomic Health, Hologic, IBM Watson, ICON plc, Johnson & Johnson, Roche Diagnostics, Sysmex America, and Thermo Fisher Scientific. Individual subject matter experts in …

Carlyle Group

Ortho Clinical Diagnostics Names Joseph M. Busky Chief Financial Officer | PR Newswire | 7/6/2020

RARITAN, N.J. Ortho Clinical Diagnostics, a global leader of in vitro diagnostics backed by The Carlyle Group, announced Joseph M. Busky has joined the Company as Chief Financial Officer, effective July 7, 2020 . Busky, who previously served as Chief Financial Officer for Vyaire Medical, Inc., has over 30 years of experience in corporate and operational finance for large, global companies across diagnostics, medical devices, telecom, and marketing services. “Joe has …

Ortho Clinical Diagnostics Names Joseph M. Busky Chief Financial Officer | PR Newswire | 7/6/2020

RARITAN, N.J. Ortho Clinical Diagnostics, a global leader of in vitro diagnostics backed by The Carlyle Group, announced Joseph M. Busky has joined the Company as Chief Financial Officer, effective July 7, 2020 . Busky, who previously served as Chief Financial Officer for Vyaire Medical, Inc., has over 30 years of experience in corporate and operational finance for large, global companies across diagnostics, medical devices, telecom, and marketing services. “Joe has …

Foresite Capital

DNAnexus raises $100M for a cloud-based analytics platform aimed at genomics and other clinical big data | TechCrunch | 6/9/2020

… specialist science and biotech investors), with participation also from previous backers GV (which has been around since almost the beginning), Foresite Capital, TPG Capital and First Round Capital. DNAnexus is also picking up a new … the platform is used by eight of the top 10 clinical diagnostics companies and seven of the world’s biggest pharmaceutical companies, which use 10 million core processing hours each month and store 28 petabytes of …

VC-backed Adaptive goes public | PE Hub | 6/27/2019

… Morgan and BofA Merrill Lynch are the lead underwriters. Adaptive’s pre-IPO backers include Viking Global Matrix Capital Management Celgene, Foresite Capital and Alexandria Venture Investments. PRESS RELEASE SEATTLE, June 26, 2019 (GLOBE NEWSWIRE) — Adaptive … precision and speed to develop products in life sciences research, clinical diagnostics, and drug discovery. We have two commercial products, and a robust clinical pipeline to diagnose, monitor and enable the treatment of diseases such …

Perceptive Advisors

DNAnexus raises $100 million to expand its genomics data analysis platform | VentureBeat | 6/9/2020

Perceptive Advisors and Northpond Ventures. DNAnexus says the funds will advance its international growth, enabling the company to serve health care and life science organizations around the world as it grows its cloud-based clinical testing offerings. A number of DNAnexus customers — which include eight of the top 10 clinical diagnostics companies, seven of the top 10 pharmaceutical companies, and over 100 enterprises — tap the platform for machine learning applications …

DNAnexus raises $100M for a cloud-based analytics platform aimed at genomics and other clinical big data | TechCrunch | 6/9/2020

… school of medicine, has raised $100 million in funding. The round, technically a Series G, is being co-led by Perceptive Advisors and Northpond Ventures (both specialist science and biotech investors), with participation also from … the platform is used by eight of the top 10 clinical diagnostics companies and seven of the world’s biggest pharmaceutical companies, which use 10 million core processing hours each month and store 28 petabytes of …

The Carlyle Group

Visiongain Report Claims there is Huge Potential Within the $34bn Immunochemistry Reagents, Analyzers and Test Kits Market | PR Newswire | 11/13/2019

… Analyzers Market . • Profiles and generic drugs revenue forecasts from 2019-2029 of these selected leading companies: • Abbott • bioMerieux • Danaher • Fujirebio • Ortho Clinical Diagnostics • Roche • Siemens • Sysmex Corporation • Thermo Fisher Scientific • Trivitron Healthcare Pvt. Ltd. • Qualitative analysis … Price Waterhouse Coopers (PWC) Pronota Qualigen Roche Royal Philips Electronics The Carlyle Group Shenzhen Mindray Bio-Medical Electronics Co Siemens Siemens Healthcare Sigma- Aldrich Span Diagnostics State Food and Drug Administration Substance Abuse and Mental …

Chris Smith Named Next Chief Executive Officer of Ortho Clinical Diagnostics | PR Newswire | 8/28/2019

RARITAN, N.J. , Aug. 27, Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that its board of directors has appointed Chris Smith as Chief Executive Officer effective September 9, 2019 . Chris will … Stephen Wise , Managing Director and Global Head of Healthcare for The Carlyle Group, which invested in Ortho Clinical Diagnostics in 2014, said, “We are thrilled to welcome Chris as Ortho’s next CEO. Chris brings over …

Goldman Sachs

Visiongain Report Claims there is Huge Potential Within the $34bn Immunochemistry Reagents, Analyzers and Test Kits Market | PR Newswire | 11/13/2019

… Analyzers Market . • Profiles and generic drugs revenue forecasts from 2019-2029 of these selected leading companies: • Abbott • bioMerieux • Danaher • Fujirebio • Ortho Clinical Diagnostics • Roche • Siemens • Sysmex Corporation • Thermo Fisher Scientific • Trivitron Healthcare Pvt. Ltd. • Qualitative analysis … and Drug Administration (FDA) US Fujirebio Diagnostics Gifu University Gimv Goldman Sachs Health Protection Agency (HPA) Hycor-Agilent Inova Diagnostics Iris Healthcare Italian National Health Service J Mitra & Co Johnson & Johnson Lilac Medicare Lyon Civil …

Adaptive Biotechnologies IPO: Five things to know - MarketWatch | 6/27/2019

Adaptive Biotechnologies Corp., a life-sciences research and clinical diagnostics company that says data from the immune system is the key to diagnosing and treating diseases, is planning to go public. The company ADPT, +0.00 … under the symbol ADPT. The underwriters on the deal are Goldman Sachs, J.P. Morgan, BofA Merrill Lynch, Cowen, Guggenheim Securities, William Blair and BTIG. Adaptive is putting together a massive database of hard-to-obtain …

Illumina Ventures

Novel Cell Sorting and Separation Markets, 2030 | PR Newswire | 10/7/2019

… analysis to estimate the likely demand for novel cell sorting products and solutions across key application areas, including research studies, clinical diagnostics, cell-based therapeutics, and other applications, in different global regions for the period … Lifesciences Icahn School of Medicine ICE Angels iCellate ICREA Ignyta Illumina Ventures IMEC immatics biotechnologies Immunomedics ImmunoQure Inabata Inbiomotion IncellDx IncoCell Tianjin Incyte Inguran Innate Pharma Innovate UK Innovative Biochips Innovative Micro Technology Inova Institute …

Illumina Ventures Closes $230 Million Fund | PR Newswire | 10/16/2017

Worldwide Offices Illumina Ventures Closes $230 Million Fund Genomics-focused fund will support breakthroughs in life science research, clinical diagnostics, novel therapeutic platforms, and other technologies impacting human health News provided by 07:00 ET Share this article SAN FRANCISCO , Oct. 16, Illumina Ventures, an independent, early-stage venture capital firm, announced today that it has raised $230 million for its first fund. Illumina Ventures was launched in the summer of …

William Blair

Adaptive Biotechnologies Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares | Globe Newswire | 7/1/2019

… joint lead book-running managers for the offering. Cowen and Guggenheim Securities acted as book-running managers for the offering. William Blair and BTIG acted as co-managers for the offering. A registration statement relating … precision and speed to develop products in life sciences research, clinical diagnostics, and drug discovery. We have two commercial products, and a robust clinical pipeline to diagnose, monitor and enable the treatment of diseases such …

Adaptive Biotechnologies IPO: Five things to know - MarketWatch | 6/27/2019

Adaptive Biotechnologies Corp., a life-sciences research and clinical diagnostics company that says data from the immune system is the key to diagnosing and treating diseases, is planning to go public. The company ADPT, +0.00 … Goldman Sachs, J.P. Morgan, BofA Merrill Lynch, Cowen, Guggenheim Securities, William Blair and BTIG. Adaptive is putting together a massive database of hard-to-obtain information on the immune system that it hopes researchers and …

Guggenheim Securities

Adaptive Biotechnologies Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares | Globe Newswire | 7/1/2019

… Co. LLC, J.P. Morgan and BofA Merrill Lynch acted as joint lead book-running managers for the offering. Cowen and Guggenheim Securities acted as book-running managers for the offering. William Blair and BTIG acted … precision and speed to develop products in life sciences research, clinical diagnostics, and drug discovery. We have two commercial products, and a robust clinical pipeline to diagnose, monitor and enable the treatment of diseases such …

Adaptive Biotechnologies IPO: Five things to know - MarketWatch | 6/27/2019

Adaptive Biotechnologies Corp., a life-sciences research and clinical diagnostics company that says data from the immune system is the key to diagnosing and treating diseases, is planning to go public. The company ADPT, +0.00 … deal are Goldman Sachs, J.P. Morgan, BofA Merrill Lynch, Cowen, Guggenheim Securities, William Blair and BTIG. Adaptive is putting together a massive database of hard-to-obtain information on the immune system that it hopes …

Merrill Lynch

VC-backed Adaptive goes public | PE Hub | 6/27/2019

… stock began trading June 27, 2019 on the NASDAQ under the ticker symbol “ADPT.” Goldman Sachs, J.P. Morgan and BofA Merrill Lynch are the lead underwriters. Adaptive’s pre-IPO backers include Viking Global Matrix Capital … precision and speed to develop products in life sciences research, clinical diagnostics, and drug discovery. We have two commercial products, and a robust clinical pipeline to diagnose, monitor and enable the treatment of diseases such …

Vertex Pharmaceuticals Incorporated (VRTX) CEO Jeff Leiden on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/1/2019

… Conference Call Participants Geoff Meacham - Barclays Phil Nadeau - Cowen & Company Michael Yee - Jefferies Alethia Young - Cantor Fitzgerald Ying Huang - BoA Merrill Lynch Geoffrey Porges - SVB Leerink Brian Abrahams - RBC Capital Markets Cory Kasimov - JPMorgan Paul … our new Chief Financial Officer. Charlie joins us from Ortho-Clinical Diagnostics, where he served as CFO and Executive Vice President of Finance. Charlie has served as CFO for public and private companies for more …

Bain Capital

Wall Street Breakfast: Worries Over Tax Reform Delays | Seeking Alpha | 11/10/2017

… William Hinman, the SEC’s recently installed director of corporation finance. Carlyle Group is exploring a sale or IPO of Ortho-Clinical Diagnostics that could be valued at more than $7B, including debt, Reuters reports. A … prized chip unit, Toshiba Memory, to a group led by Bain Capital for $18B. Nintendo plans to up the pace of production for its Switch game console next year, WSJ reports, showing the company’s deepening …

U.S. stock index futures are heading lower, while the dollar | Seeking Alpha | 11/10/2017

… William Hinman, the SEC’s recently installed director of corporation finance. Carlyle Group is exploring a sale or IPO of Ortho-Clinical Diagnostics that could be valued at more than $7B, including debt, Reuters reports. A … prized chip unit, Toshiba Memory, to a group led by Bain Capital for $18B. Nintendo plans to up the pace of production for its Switch game console next year, WSJ reports, showing the company’s deepening …

Mayo Clinic

numares Announces Winton Gibbons as New President of US Subsidiary - Business Wire | 6/8/2020

… a distinctive nuclear magnetic resonance (NMR) technology to identify metabolite constellations for diagnostic purposes. Just recently, numares and US-based Mayo Clinic Laboratories announced their collaboration to develop new diagnostic tests. “I am excited to … to develop advanced analytical tests for high-throughput use in clinical diagnostics and life science research. The company’s AXINON ® system employs nuclear magnetic resonance (NMR) spectroscopy to create a spectrum standardized by Magnetic Group Signaling …

Mount Sinai Health System

Bio-Techne And Kantaro Biosciences Announce Partnership To Develop And Scale Production Of COVID-19 Serology Test | PR Newswire | 5/19/2020

MINNEAPOLIS and NEW YORK , May 19, Bio-Techne Corporation (NASDAQ: TECH ) and the Mount Sinai Health System in New York , through its commercial affiliate Kantaro Biosciences LLC (Kantaro), today announced a partnership to initiate scaled manufacturing and distribution of testing kits based on the Mount Sinai -developed COVID-19 serology test. Kantaro Biosciences is a joint venture between Mount Sinai Health System (“ Mount Sinai “) and Renalytix AI (LSE: RENX) formed …

Sinai Health System

Bio-Techne And Kantaro Biosciences Announce Partnership To Develop And Scale Production Of COVID-19 Serology Test | PR Newswire | 5/19/2020

MINNEAPOLIS and NEW YORK , May 19, Bio-Techne Corporation (NASDAQ: TECH ) and the Mount Sinai Health System in New York , through its commercial affiliate Kantaro Biosciences LLC (Kantaro), today announced a partnership to initiate scaled manufacturing and distribution of testing kits based on the Mount Sinai -developed COVID-19 serology test. Kantaro Biosciences is a joint venture between Mount Sinai Health System (“ Mount Sinai “) and Renalytix AI (LSE: RENX) formed …

Medical Center

Live updates on COVID-19: March 16-31 | Modern Healthcare | 4/24/2020

… patient rights could improve the quality of care that patients receive and foster better communication between providers and patients. Boston Medical Center Health System furloughs around 700 employees 4:05 PM CT on 3/31/2020 Boston Medical … Northwell is using a system from Irish biotechnology company Technopath Clinical Diagnostics that shreds and disinfects infectious waste, killing bacteria, spores and pathogens. The resulting waste—which Northwell describes as “confetti-like” in a news …

Northwell Health

Northwell Implements New On-site Laboratory Treatment Technology for COVID-19 Infected Medical Waste | Business Wire | 3/30/2020

LAKE SUCCESS, N.Y.- To minimize the risk of spreading COVID-19, Northwell Health has become the first US health system to implement a new technology that breaks down medical waste from laboratory testing in a safe, environmentally friendly way. Developed by Irish-based Technopath Clinical Diagnostics, the Envetec 200 system simultaneously shreds and disinfects infectious waste using a patented destruction and disinfection process that kills all COVID-19 viruses along …

MD Anderson Cancer Center

Viracor Eurofins Expands Its Clinical Diagnostic Footprint to Oncology | PR Newswire | 12/11/2019

Clinical Diagnostics group. Dr. Eterovic will lead the development and growth of oncology clinical diagnostic solutions to benefit our healthcare clients and their patients. Dr. Eterovic joins us from MD Anderson Cancer Center, where she was Associate Professor and Director of the Cancer Genomics Laboratory, as well as a driving force in the implementation of precision medicine at the prestigious institute; establishing a genomics laboratory for their NGS (Next Generation …

University Hospital

DNA repeats—the genome’s dark matter | Phys Org | 11/22/2019

… A research team led by Franz-Josef Müller at the Max Planck Institute for Molecular Genetics in Berlin and the University Hospital of Schleswig-Holstein in Kiel recently shed light on this inaccessible region of … look at this.” The physician also envisions numerous applications in clinical diagnostics. After all, repetitive regions are involved in the development of cancer, and the new method is relatively inexpensive and fast. Müller is determined …

Children's Hospital

LabRoots Continues to Strengthen its Educational Presence in Clinical Diagnostics & Research at 10th Annual Virtual Event | PRWeb | 11/7/2019

LabRoots Continues to Strengthen its Educational Presence in Clinical Diagnostics & Research at 10th Annual Virtual Event Share Article Learn the latest scientific disciplines, advances in laboratory testing, and new technologies and treatments in every stage of patient care on November 14th YORBA LINDA, Calif. LabRoots , the leading scientific social networking website offering premier, interactive virtual events and webinars, will be hosting presentations during the one-day agenda at its free …

Massachusetts General Hospital

MicroMedicine to Launch Automated, Microfluidics-based Cell Isolation Technology at the Society for Immunotherapy of Cancer (SITC) Meeting | PR Newswire | 11/5/2019

Massachusetts General Hospital in 2015 by prominent physicians and researchers, MicroMedicine is committed to transforming research, clinical diagnostics, and cell therapy with novel innovations. The patented microfluidic platform can be utilized for multiple applications, including cell isolation, cell concentration, and fluid exchange. The company is located in the heart of Boston’s life sciences ecosystem in Waltham, Massachusetts . For more information about MicroMedicine, Inc., please call 617-744-1918, visit micromedicine.com or https …

Cleveland Clinic

Global Genitourinary Partnering Deal Trends, Players and Financials Directory 2014-2019 | PR Newswire | 10/24/2019

… Hospital Caldera Pharmaceuticals CamelBak Cara Therapeutics CARB-X Cardio Renal Society of America Casper Pharma Celtic Biotech ChemoCentryx CJ Corp Cleveland Clinic Clinipace Worldwide Codexis Cogentix Medical Collaborative Study Group Columbia University Control Flo Medical … Pharmaceuticals Noventure Novo Nordisk Nxstage Medical OPKO Health Organovo Ortho-Clinical Diagnostics Otsuka Outpost Medicine Oxford Immunotec Palette Life Sciences Pansend Par Pharmaceutical Patheon N.V. Perlara Pfizer Phadia Pharmacological research Institute Mario Negri PharmaSwiss Pharmstandard …

Nassau University Medical Center

Dr. Chirag Parikh | 10/22/2019

NEW YORK, Oct. 14, 2019 /PRNewswire/ – Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announced today the appointment of leading kidney investigator and clinician Dr. Chirag Parikh … India and subsequently completed his internal medicine residency at the Nassau University Medical Center and SUNY at Stony Brook in New York, followed by his fellowship in Nephrology and Hypertension and UNOS Transplant Certification at …

University Medical Center

Johns Hopkins Director of Nephrology Chirag Parikh Joins RenalytixAI Board | PR Newswire | 10/14/2019

NEW YORK Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announced today the appointment of leading kidney investigator and clinician Dr. Chirag Parikh to the Renalytix board … and subsequently completed his internal medicine residency at the Nassau University Medical Center and SUNY at Stony Brook in New York , followed by his fellowship in Nephrology and Hypertension and UNOS Transplant Certification at the …

HCA

New perspectives for viability studies with high-content analysis Raman spectroscopy (HCA-RS) | Nature | 9/2/2019

… rendering the method less attractive for most laboratories. In this work, we present a new high-content analysis Raman spectroscopy (HCA-RS) platform that overcomes the current challenges of conventional Raman spectroscopy implementations. HCA-RS … SVM for Raman spectral data analysis 33 , 35 , 36 , 37 . Clinical diagnostics of leukemia cells from healthy volunteer as well as patients are also investigated using SVM 38 . In this work first, the SVM classifier …

St. John Providence

Luminex Corporation Receives FDA Clearance for ARIES Group A Strep Assay | PR Newswire | 10/31/2017

… welcome addition to the ARIES® System test menu.” Dr. Ted E. Schutzbank , Technical Director, Specialized Testing and Microbiology at Ascension/St. John Providence added: “While the use of rapid antigen detection kits has been the … a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. We accelerate reliable answers while simplifying complexity and deliver …

Children's Hospital Los Angeles, Los Angeles CA

Luminex Corporation Receives FDA Clearance for ARIES Group A Strep Assay | PR Newswire | 10/31/2017

… it comes to dealing with infectious diseases,” said Dr. Jennifer Dien Bard , Director, Clinical Microbiology and Virology Laboratory at the Children’s Hospital Los Angeles. “Having tests that are easy to use and require only minimal … a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. We accelerate reliable answers while simplifying complexity and deliver …

CDPHP

RenalytixAI Partners with Capital District Physicians’ Health Plan, Inc. on KidneyIntelX™ | PR Newswire | 10/17/2019

NEW YORK Renalytix AI plc (AIM: RENX), a developer of artificial intelligence enabled clinical diagnostics for kidney disease, announces that Capital District Physicians’ Health Plan, Inc. (CDPHP ® ), a physician led health insurance provider, has adopted coverage determination policies that will provide KidneyIntelX™ for qualified CDPHP members who have Type 2 diabetes and chronic kidney disease (diabetic kidney disease or “DKD”). In the United States , approximately 12 million people currently have …

RenalytixAI Partners with Capital District Physicians’ Health Plan, Inc. on KidneyIntelX™ | BioSpace | 10/17/2019

RenalytixAI Partners with Capital District Physicians’ Health Plan, Inc. on KidneyIntelX™ Published: Oct 17, 2019 Effective October 16, KidneyIntelX will be covered for reimbursement for qualified members NEW YORK , Oct. 17, 2019 /PRNewswire/ – Renalytix AI plc (AIM: RENX), a developer of artificial intelligence enabled clinical diagnostics for kidney disease, announces that Capital District Physicians’ Health Plan, Inc. (CDPHP ® ), a physician led health insurance provider, has adopted coverage determination policies that …

Cigna

Prognos Partners with Datavant, Using Health Data Ecosystem to Enhance AI Analytics for Customers | PR Newswire | 6/27/2019

clinical diagnostics information in 50 disease areas, with nearly 24 billion medical records for 200 million patients. Prognos has 1,000 extensive proprietary and learning clinical algorithms to enable earlier patient identification for enhanced treatment decision-making, risk management and quality improvement. The company is supported by a $42M investment from Safeguard Scientifics, Inc., Merck Global Health Innovation Fund, Cigna, GIS Strategic Ventures, Hikma Ventures, Hermed Capital, and Maywic Select Investments …

Prognos and Proclivity Systems Partner to Enable Life Science Brands to Harness Real-world Clinical Signals to Optimize HCP Programmatic Advertising | PR Newswire | 6/20/2019

clinical diagnostics information in 50 disease areas, with over 20 billion medical records for 200 million patients. Prognos has over 1,000 extensive proprietary and learning clinical algorithms to enable earlier patient identification for enhanced treatment decision-making, risk management, and quality improvement. The company is supported by a $42M investment from Safeguard Scientifics, Inc., Merck Global Health Innovation Fund, Cigna Ventures, GIS Strategic Ventures, Hikma Ventures, Hermed Capital, and Maywic …

Chris Smith

Ortho Clinical Diagnostics Names Joseph M. Busky Chief Financial Officer | PR Newswire | 7/6/2020

RARITAN, N.J. Ortho Clinical Diagnostics, a global leader of in vitro diagnostics backed by The Carlyle Group, announced Joseph M. Busky has joined the Company as Chief Financial Officer, effective July 7, 2020 . Busky, who … models to yield growth and create long-term value,” said Chris Smith , chief executive officer, Ortho Clinical Diagnostics. “As Ortho Clinical Diagnostics continues to innovate to bring fast, accurate, reliable testing solutions to market, Joe’s …

Robin Smith

Orig3n Announces Comprehensive Solution To Provide COVID-19 Testing For Boarding Schools | PR Newswire | 6/23/2020

BOSTON Orig3n, Inc., a Boston -based company pioneering the future of wellness and health through diagnostics, genetics and biotechnology, has announced a comprehensive solution to provide COVID-19 testing for boarding schools. Orig3n is offering the Orig3n 2019 Novel Coronavirus (COVID-19) Test under an Emergency Use Authorization (EUA) from FDA to authorized healthcare providers and institutions nationwide. The test detects the presence of nucleic acid from the virus that …

Laura Wood

Global Market Outlook for the Coronavirus Diagnostics Market to 2027 | PR Newswire | 6/19/2020

… Coronavirus Diagnostics Market include Abbott, Beckman Coulter , Becton, Dickinson and Company, bioMerieux, Bio-Rad Laboratories, GSK Biologicals, Hologic, Lonza, Ortho-Clinical Diagnostics, PerkinElmer, Qiagen and Roche Diagnostics. What the report offers: Market share assessments for … focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood , Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 …

Graham Mullis

Novacyt shares jump after launch of new COVID-19 testing products | Yahoo News | 6/18/2020

By Sudip Kar-Gupta PARIS (Reuters) - Healthcare and clinical diagnostics company Novacyt ALNOV.PA NCYT.L , whose shares have surged on the back of its COVID-19 testing products, on Thursday announced the launch of three new … further support through the launch of these new products,” CEO Graham Mullis said. Novacyt has singled itself out with a test able to detect the new coronavirus in less than two hours. Standard testing, which …

Scott Becker

These Labs Rushed to Test for Coronavirus. They Had Few Takers. | Yahoo News | 5/21/2020

… testing response in a public health crisis, there is, in fact, little coordination among public and private health labs, said Scott Becker, chief executive of the Association of Public Health Laboratories, an association of state … University of California, San Diego and the for-profit Eurofins Clinical Diagnostics, said they were surprised when they heeded the call to scale up testing in March but were not sent as many samples as …

Christopher Hill

Ortho’s COVID-19 IgG Antibody Test Receives CE Mark | PR Newswire | 5/18/2020

… to run - Ortho has already begun shipping its antibody test to customers in highly impacted geographies and plans to manufacture several million COVID-19 antibody tests each month RARITAN, N.J. , May 18, Ortho Clinical Diagnostics, a global leader of in vitro diagnostics with a rich history of bringing critical tests for infectious diseases to market, today announced its second COVID-19 antibody test—the VITROS ® Immunodiagnostic Products Anti-SARS-CoV …

Chuck Kummeth

Bio-Techne Releases Third Quarter Fiscal 2020 Results | PR Newswire | 4/30/2020

… indicative of the resolve and energy our teams around the world have to succeed in these trying times. I want to thank all of our employees for their commitment and hard work,” said Chuck Kummeth , President and Chief Executive Officer of Bio-Techne. “A finish of 6% organic growth is a great accomplishment for the company, given the unprecedented challenges we all faced with the COVID-19 virus pandemic during …

Louise Heavens

Novacyt signs coronavirus test supply contract with UK government - Nasdaq | 4/27/2020

Healthcare and clinical diagnostics company Novacyt has signed a supply contract with the UK’s Department of Health & Social Care (DHSC) for its product aimed at testing for the presence of the coronavirus, the company said … expand the agreement. (Reporting by Sudip Kar-Gupta, editing by Louise Heavens) (( ; +33 1 49 49 53 84;)) The views and opinions expressed herein are the views and opinions of the author and do not …

Donald Trump

Live updates on COVID-19: March 16-31 | Modern Healthcare | 4/24/2020

… American Hospital Association wants HHS to immediately send billions of dollars to hospitals under the stimulus package signed by President Donald Trump last week. The department should direct Medicare Administrative Contractors “distribute funds to every … Northwell is using a system from Irish biotechnology company Technopath Clinical Diagnostics that shreds and disinfects infectious waste, killing bacteria, spores and pathogens. The resulting waste—which Northwell describes as “confetti-like” in a news …

Andrew Cuomo

Mount Sinai gets OK to do antibody testing | Crain’s New York Business | 4/21/2020

… to fight off the virus that causes Covid-19. Testing for this type of immunity has been identified by Gov. Andrew Cuomo as key to reopening the state’s economy and lifting restrictions on social interaction … granted emergency authorization by the FDA. They are Cellex, Ortho Clinical Diagnostics and Chembio Diagnostic Systems. The New York Times reported that some antibody tests on the market have inaccurately identified people as having antibodies …

Carlos Cordon-Cardo

Mount Sinai gets OK to do antibody testing | Crain’s New York Business | 4/21/2020

… and the need to connect to more commercial lab partners that can increase the number of tests conducted, said Dr. Carlos Cordon-Cardo, Mount Sinai’s chair of pathology. He predicted that Mount Sinai would be … granted emergency authorization by the FDA. They are Cellex, Ortho Clinical Diagnostics and Chembio Diagnostic Systems. The New York Times reported that some antibody tests on the market have inaccurately identified people as having antibodies …

Barbara Zucker

Technopath’s Pioneering Technology for the Treatment of COVID-19 Infected Medical Waste Is Fast-tracked for Immediate Use at New York’s Largest Health Care Provider | PR Newswire | 3/30/2020

NEW YORK and BALLINA, Ireland , March 30, 2020 /PRNewswire/ – Technopath Clinical Diagnostics today announced that Northwell Health, New York State’s largest healthcare provider with 23 hospitals and nearly 800 outpatient facilities, is minimizing the risk … next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra /Northwell and the Hofstra Northwell School of Graduate Nursing and Physician Assistant Studies. For information on our more …

Michael Dowling

Technopath’s Pioneering Technology for the Treatment of COVID-19 Infected Medical Waste Is Fast-tracked for Immediate Use at New York’s Largest Health Care Provider | PR Newswire | 3/30/2020

NEW YORK and BALLINA, Ireland , March 30, 2020 /PRNewswire/ – Technopath Clinical Diagnostics today announced that Northwell Health, New York State’s largest healthcare provider with 23 hospitals and nearly 800 outpatient facilities, is minimizing the risk … the health and safety challenges posed by COVID-19,” said Michael Dowling , Northwell president and CEO. “This new technology allows us to remove the unknown risk exposure when disposing of medical waste while avoiding the …

Dwayne Breining

Northwell Implements New On-site Laboratory Treatment Technology for COVID-19 Infected Medical Waste | Business Wire | 3/30/2020

… technology that breaks down medical waste from laboratory testing in a safe, environmentally friendly way. Developed by Irish-based Technopath Clinical Diagnostics, the Envetec 200 system simultaneously shreds and disinfects infectious waste using a patented … the very latest and innovative technologies available in healthcare,” said Dwayne Breining, MD , executive director of Northwell Labs. “We have carefully evaluated our options to eliminate any potential risks associated with the new large-scale …

Chad Robins

Adaptive Biotechnologies and Microsoft expand partnership to decode COVID-19 immune response and provide open data access | PR Newswire | 3/20/2020

… to the virus and the disease patterns that can be inferred from studying these data at the population level,” said Chad Robins , CEO and co-founder of Adaptive Biotechnologies. “Immune response data may enable detection … precision and speed to develop products in life sciences research, clinical diagnostics, and drug discovery. We have two commercial products, and a robust clinical pipeline to diagnose, monitor and enable the treatment of diseases such …

Sara Peerun

Visiongain Publishes Blood Culture Tests Market 2019-2029 Report | PR Newswire | 12/2/2019

clinical diagnostics laboratories for the detection of bacterial, fungal, and mycobacterial infections is expected to be the driving factor of blood culture tests market. To find out more about this report please contact Sara Peerun at or refer to our website: https://www.visiongain.com/report/blood-culture-tests-market-report-2019-2029/ Factors Restraining the Market Growth: • The diagnostic products, such as instruments, kits, reagents, media, and assays, undergo rigorous clinical trials …

Jeff Christensen

Luminex Corporation to Present at the Piper Jaffray 31st Annual Healthcare Conference on December 4, 2019 | PR Newswire | 11/25/2019

… clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. We accelerate reliable answers while simplifying complexity and deliver certainty with a seamless experience. To learn more about Luminex, please visit us at luminexcorp.com. Contact Jeff Christensen Senior Director, Investor Relations [email protected] 512-249-3033 SOURCE Luminex Corporation Related Links http://www.luminexcorp.com …

Sarah Smith

Polymerase Chain Reaction (PCR) Global Market - Forecast to 2025 | PR Newswire | 11/7/2019

… testing, technological advancements and growing demand for rapid diagnostic tests. However, factors like high cost of commercial PCR assays in clinical diagnostics, lack of awareness and requirement of skilled labor, development of alternate technologies and … all market research reports from top publishers For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +1 (718) 213 4904 Website: www.reportbuyer.com SOURCE ReportBuyer Related Links http://www.reportbuyer.com …

Jack Meehan

Bio Rad Laboratories, Inc. (BIO) CEO Norman Schwartz on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 11/1/2019

Bio Rad Laboratories, Inc. (NYSE: BIO ) Q3 2019 Earnings Conference Call October 31, 2019 5:00 PM ET Company Participants Ronald Hutton - VP & Treasurer Ilan Daskal - EVP & CFO Norman Schwartz - Chairman, CEO & President Andrew Last - EVP & COO Annette Tumolo - EVP & President, Life Science Group John Hertia - EVP & President, Clinical Diagnostics Group Conference Call Participants Brandon Couillard - Jefferies Jack Meehan - Barclays Bank Operator Ladies and gentlemen, thank you for standing by, and …

Brandon Couillard

Bio Rad Laboratories, Inc. (BIO) CEO Norman Schwartz on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 11/1/2019

Bio Rad Laboratories, Inc. (NYSE: BIO ) Q3 2019 Earnings Conference Call October 31, 2019 5:00 PM ET Company Participants Ronald Hutton - VP & Treasurer Ilan Daskal - EVP & CFO Norman Schwartz - Chairman, CEO & President Andrew Last - EVP & COO Annette Tumolo - EVP & President, Life Science Group John Hertia - EVP & President, Clinical Diagnostics Group Conference Call Participants Brandon Couillard - Jefferies Jack Meehan - Barclays Bank Operator Ladies and gentlemen, thank you for standing by, and …

Darren Lee

Transplant Genomics, Inc. Founders Awarded US Patent Covering Detection of “Silent” Sub-Clinical Rejection in Stable Kidney Transplant Recipients | Markets Insider | Business Insider | 10/29/2019

Darren Lee , Vice President Transplant Marketing Transplant Genomics-Eurofins U.S. Clinical Diagnostics 508-337-6200 or [email protected] About Transplant Genomics, Inc. Transplant Genomics, Inc. (“TGI”) is a molecular diagnostics company committed to improving organ transplant outcomes, with an initial focus on kidney transplant recipients. Working with the transplant community, TGI is commercializing a suite of tests enabling diagnosis and prediction of transplant recipient immune status. Test results will support clinicians with …

Gilles Martin

Eurofins Reports Strong Organic Growth (over 6%) in Q3 2019 | Business Wire | 10/28/2019

… efforts to determine and agree on exact damages will be on going for a while. Comment from the CEO, Dr. Gilles Martin: “Q3 2019 was a very positive quarter for Eurofins as the Group demonstrated … with a range of superior new product launches. In France, Clinical Diagnostics continued to perform in line with management’s expectations with a positive organic growth even if below Group average. In North America, Eurofins’ BioPharma …

Mark Calarco

National Prescription Drug Take Back Day will accept vapes, cartridges for the first time | Yahoo News | 10/26/2019

Mark Calarco , the national medical director for clinical diagnostics at American Addiction Centers , tells Yahoo Lifestyle: “While we will have to wait to see if this new initiative is actually effective, it does send a powerful message that vaping is not inherently safe and people may need to take action to protect their health. In light of the recent deaths and health consequences linked to vaping, this is a step …

Hans Cobben

BlueBee Establishes Data Center in Mainland China, Expanding Global Coverage for Its Genomics Data Platform | PR Newswire | 10/9/2019

… globe. “We were drawn to setting up our mainland China data center to meet the demands of partner clients,” says Hans Cobben , CEO BlueBee. “Serving the global community remains at the helm of our mandate … medical devices. BlueBee serves molecular assay and service providers in clinical diagnostics, therapeutics, and research with a shared mission—to power precision medicine. BlueBee software solutions are available for deployment globally, including most recently—mainland …

Craig Overpeck

BioInformatics New Product Launch – RateMyProduct, Rapid Product Assessment Tool for Life Science Suppliers | PRWeb | 9/18/2019

… versatile. Our methodology equally supports instrumentation and consumables, as well as new products and those already on the market,” commented Craig Overpeck, chief executive officer of Science and Medicine Group. “Over the last few months … the premier research and advisory firm serving the life science, clinical diagnostics, and analytical instrument industries. By leveraging our expert network of more than 40,000 profiled life scientists, the company has supported more than 500 …

New York, New York

A hospital lab director vetted a ‘multitude’ of coronavirus tests. Here are the ones that are the most accurate and how you should use them. | Business Insider | 5/26/2020

The coronavirus outbreak in New York on May 13, 2020. REUTERS/Shannon Stapleton This story is available exclusively on Business Insider Prime. Join BI Prime and start reading now. Dr. Robert Babkowski, laboratory director at Stamford Health, vetted a “multitude” of coronavirus tests. He told Wall Street analysts at Jefferies that the best ones are made by Abbott Laboratories, Roche, and Ortho Clinical Diagnostics, according to a note the analysts …

State of New York

A hospital lab director vetted a ‘multitude’ of coronavirus tests. Here are the ones that are the most accurate and how you should use them. | Business Insider | 5/26/2020

The coronavirus outbreak in New York on May 13, 2020. REUTERS/Shannon Stapleton This story is available exclusively on Business Insider Prime. Join BI Prime and start reading now. Dr. Robert Babkowski, laboratory director at Stamford Health, vetted a “multitude” of coronavirus tests. He told Wall Street analysts at Jefferies that the best ones are made by Abbott Laboratories, Roche, and Ortho Clinical Diagnostics, according to a note the analysts …

York, Pennsylvania

A hospital lab director vetted a ‘multitude’ of coronavirus tests. Here are the ones that are the most accurate and how you should use them. | Business Insider | 5/26/2020

The coronavirus outbreak in New York on May 13, 2020. REUTERS/Shannon Stapleton This story is available exclusively on Business Insider Prime. Join BI Prime and start reading now. Dr. Robert Babkowski, laboratory director at Stamford Health, vetted a “multitude” of coronavirus tests. He told Wall Street analysts at Jefferies that the best ones are made by Abbott Laboratories, Roche, and Ortho Clinical Diagnostics, according to a note the analysts …

State of Texas

National coronavirus updates: US death toll represents a quarter of the world’s total | 4/25/2020

… electronics factory in Kokomo, Indiana, working on shields and ventilators. About 60 Toyota workers are making protective equipment in Kentucky, Texas, Michigan and Alabama.Most automakers in the U.S. temporarily stopped making vehicles about a month … a test’s benefits could outweigh any risks.Three companies – DiaSorin, Ortho-Clinical Diagnostics and Autobio Diagnostics – received the authorizations. The tests were restricted to use in authorized laboratories, and the FDA cautioned that all three came …

State of Georgia

National coronavirus updates: US death toll represents a quarter of the world’s total | 4/25/2020

… toll has surpassed 53,000 people, according to Hopkins.Globally, there have been more than 2.8 million cases with more than 202,000 deaths.Georgia state officials are moving ahead with plans to allow some nonessential businesses to reopen … a test’s benefits could outweigh any risks.Three companies – DiaSorin, Ortho-Clinical Diagnostics and Autobio Diagnostics – received the authorizations. The tests were restricted to use in authorized laboratories, and the FDA cautioned that all three came …

State of Alaska

National coronavirus updates: US death toll represents a quarter of the world’s total | 4/25/2020

… authorizations, a lower regulatory standard used when the FDA believes a test’s benefits could outweigh any risks.Three companies – DiaSorin, Ortho-Clinical Diagnostics and Autobio Diagnostics – received the authorizations. The tests were restricted to use in … businesses reluctant to reopen. The states of Georgia, Oklahoma and Alaska started loosening restrictions on businesses despite warnings from experts that such steps might be coming too soon. Some owners said they weren’t yet ready …

State of Michigan

National coronavirus updates: US death toll represents a quarter of the world’s total | 4/25/2020

… factory in Kokomo, Indiana, working on shields and ventilators. About 60 Toyota workers are making protective equipment in Kentucky, Texas, Michigan and Alabama.Most automakers in the U.S. temporarily stopped making vehicles about a month ago … a test’s benefits could outweigh any risks.Three companies – DiaSorin, Ortho-Clinical Diagnostics and Autobio Diagnostics – received the authorizations. The tests were restricted to use in authorized laboratories, and the FDA cautioned that all three came …

Detroit, Michigan

National coronavirus updates: US death toll represents a quarter of the world’s total | 4/25/2020

… hand sanitizer, which early in the crisis were in short supply.At Ford, over 800 people returned to work at four Detroit-area sites. General Motors has about 400 at a now-closed transmission plant in … a test’s benefits could outweigh any risks.Three companies – DiaSorin, Ortho-Clinical Diagnostics and Autobio Diagnostics – received the authorizations. The tests were restricted to use in authorized laboratories, and the FDA cautioned that all three came …

State of Florida

National coronavirus updates: US death toll represents a quarter of the world’s total | 4/25/2020

… authorizations, a lower regulatory standard used when the FDA believes a test’s benefits could outweigh any risks.Three companies – DiaSorin, Ortho-Clinical Diagnostics and Autobio Diagnostics – received the authorizations. The tests were restricted to use in … figures. The actual death toll is believed to be far higher.Florida to receive shipment of antibody tests by next week, governor saysFlorida Gov. Ron DeSantis says Florida should receive a shipment of antibody test kits …

Atlanta, Georgia

National coronavirus updates: US death toll represents a quarter of the world’s total | 4/25/2020

… authorizations, a lower regulatory standard used when the FDA believes a test’s benefits could outweigh any risks.Three companies – DiaSorin, Ortho-Clinical Diagnostics and Autobio Diagnostics – received the authorizations. The tests were restricted to use in … Georgia governor’s announcement that he would not be reopening his Atlanta gym right away. “I feel like if we do this too soon, we’ll see a spike in cases and we’re back to square one …

Kokomo, Indiana

National coronavirus updates: US death toll represents a quarter of the world’s total | 4/25/2020

… sites. General Motors has about 400 at a now-closed transmission plant in suburban Detroit and an electronics factory in Kokomo, Indiana, working on shields and ventilators. About 60 Toyota workers are making protective equipment … a test’s benefits could outweigh any risks.Three companies – DiaSorin, Ortho-Clinical Diagnostics and Autobio Diagnostics – received the authorizations. The tests were restricted to use in authorized laboratories, and the FDA cautioned that all three came …

State of Indiana

National coronavirus updates: US death toll represents a quarter of the world’s total | 4/25/2020

… General Motors has about 400 at a now-closed transmission plant in suburban Detroit and an electronics factory in Kokomo, Indiana, working on shields and ventilators. About 60 Toyota workers are making protective equipment in … a test’s benefits could outweigh any risks.Three companies – DiaSorin, Ortho-Clinical Diagnostics and Autobio Diagnostics – received the authorizations. The tests were restricted to use in authorized laboratories, and the FDA cautioned that all three came …

State of Kentucky

National coronavirus updates: US death toll represents a quarter of the world’s total | 4/25/2020

… an electronics factory in Kokomo, Indiana, working on shields and ventilators. About 60 Toyota workers are making protective equipment in Kentucky, Texas, Michigan and Alabama.Most automakers in the U.S. temporarily stopped making vehicles about a … a test’s benefits could outweigh any risks.Three companies – DiaSorin, Ortho-Clinical Diagnostics and Autobio Diagnostics – received the authorizations. The tests were restricted to use in authorized laboratories, and the FDA cautioned that all three came …

State of Oklahoma

National coronavirus updates: US death toll represents a quarter of the world’s total | 4/25/2020

… authorizations, a lower regulatory standard used when the FDA believes a test’s benefits could outweigh any risks.Three companies – DiaSorin, Ortho-Clinical Diagnostics and Autobio Diagnostics – received the authorizations. The tests were restricted to use in … pandemic-wounded businesses reluctant to reopen. The states of Georgia, Oklahoma and Alaska started loosening restrictions on businesses despite warnings from experts that such steps might be coming too soon. Some owners said they weren’t …

State of Washington

COVID-19 antibody tests are raising as many questions as they answer | 5/28/2020

… be trusted. Yet the tests are getting better, says Alex Greninger, a virologist and diagnostics expert at the University of Washington. Months after allowing antibody tests into the market without regulatory vetting, the US Food … of their assay, using different antigens. For example, when Ortho Clinical Diagnostics developed its assay, Chockalingam Palaniappan, the company’s chief innovation officer, says it tested the nucleocapsid, the spike protein, and the SARS-CoV-2 …

State of California

Pop-Up Testing Lab Shows Volunteer Spirit Against Deadly Pandemic | National Institutes of Health (NIH) | 6/10/2020

… before another machine can detect whether that RNA comes from the coronavirus. Credit: Max & Jules Photography. On March 19, 2020, California became the first U. S. state to issue a stay-at-home order to … NIH-supported structural biochemist with no experience in virology or clinical diagnostics, decided that she and her IGI colleagues could establish a pop-up testing lab at their facility. Their job: boost the SARS-CoV …

Washington, District of Columbia

CORONAVIRUS UPDATES: 1,329,799 infected, 79,528 deaths in U.S. | 5/11/2020

… that the Wuhan laboratory is “most likely” the source of the coronavirus outbreak based on “circumstantial evidence,” according to the Washington Times . “All other possible places of the virus’ origin have been proven to be … coronavirus antibody tests to determine immunity. Chembio Diagnostic Systems, Ortho Clinical Diagnostics, and Abbott Laboratories. Wednesday, April 15 The number of people infected with the coronavirus in the U.S. climbed to 609,685. The number of …

Los Angeles, California

COVID-19 Testing Provider Curative Acquires KorvaLabs | Globe Newswire | 5/19/2020

… continue to be produced and processed in KorvaLabs’ San Dimas, CA facilities May 19, 2020 10:00 ET Source: Curative Inc. LOS ANGELES, May 19, 2020 (GLOBE NEWSWIRE) – COVID-19 testing startup Curative Inc. announced today … more than 25 years of experience in biochemical analytics and clinical diagnostics. In addition to its CLIA certification, KorvaLabs has also been inspected and fully licensed by the California Department of Public Health and the …

Boston, Massachusetts

Orig3n Announces Comprehensive Solution To Provide COVID-19 Testing For Boarding Schools | PR Newswire | 6/23/2020

BOSTON Orig3n, Inc., a Boston -based company pioneering the future of wellness and health through diagnostics, genetics and biotechnology, has announced a comprehensive solution to provide COVID-19 testing for boarding schools. Orig3n is offering the Orig3n 2019 Novel Coronavirus (COVID-19) Test under an Emergency Use Authorization (EUA) from FDA to authorized healthcare providers and institutions nationwide. The test detects the presence of nucleic acid from the virus that …